| Boceprevir for untreated chronic HCV genotype 1 infection F Poordad, J McCone Jr, BR Bacon, S Bruno, MP Manns, MS Sulkowski, ... New England Journal of Medicine 364 (13), 1195-1206, 2011 | 2926 | 2011 |
| Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ... Hepatology 45 (3), 579-587, 2007 | 654 | 2007 |
| Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study S Bruno, E Silini, A Crosignani, F Borzio, G Leandro, F Bono, M Asti, ... Hepatology 25 (3), 754-758, 1997 | 418 | 1997 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658, 2010 | 345 | 2010 |
| Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections B Oliviero, S Varchetta, E Paudice, G Michelone, M Zaramella, D Mavilio, ... Gastroenterology 137 (3), 1151-1160. e7, 2009 | 319 | 2009 |
| Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities E Silini, F Bono, A Cividini, A Cerino, S Bruno, S Rossi, G Belloni, ... Hepatology 21 (2), 285-290, 1995 | 302 | 1995 |
| The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis B Palmentieri, I De Sio, V La Mura, M Masarone, R Vecchione, S Bruno, ... Digestive and Liver Disease 38 (7), 485-489, 2006 | 272 | 2006 |
| Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study M Borzio, S Bruno, M Roncalli, GC Mels, G Ramella, F Borzio, G Leandro, ... Gastroenterology 108 (3), 812-817, 1995 | 217 | 1995 |
| Sustained virologic response prevents the development of esophageal varices in compensated, Child‐Pugh class A hepatitis C virus–induced cirrhosis. A 12‐year prospective follow … S Bruno, A Crosignani, C Facciotto, S Rossi, L Roffi, A Redaelli, ... Hepatology 51 (6), 2069-2076, 2010 | 197 | 2010 |
| Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study E Silini, R Bottelli, M Asti, S Bruno, ME Candusso, S Brambilla, F Bono, ... Gastroenterology 111 (1), 199-205, 1996 | 197 | 1996 |
| Prevalence and etiology of altered liver tests: a population‐based survey in a Mediterranean town GM Pendino, A Mariano, P Surace, CA Caserta, MT Fiorillo, A Amante, ... Hepatology 41 (5), 1151-1159, 2005 | 195 | 2005 |
| Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis S Raimondi, S Bruno, MU Mondelli, P Maisonneuve Journal of hepatology 50 (6), 1142-1154, 2009 | 193 | 2009 |
| Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C C Cammą, S Bruno, V Di Marco, D Di Bona, M Rumi, M Vinci, C Rebucci, ... Hepatology 43 (1), 64-71, 2006 | 190 | 2006 |
| Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients M Pietrogrande, S De Vita, AL Zignego, P Pioltelli, D Sansonno, S Sollima, ... Autoimmunity reviews 10 (8), 444-454, 2011 | 186 | 2011 |
| Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen‐year prospective cohort study S Bruno, A Crosignani, P Maisonneuve, S Rossi, E Silini, MU Mondelli Hepatology 46 (5), 1350-1356, 2007 | 184 | 2007 |
| Repeated paracentesis and iv albumin infusion to treat ‘tense’ascites in cirrhotic patients: a safe alternative therapy F Salerno, S Badalamenti, P Incerti, S Tempini, B Restelli, S Bruno, ... Journal of Hepatology 5 (1), 102-108, 1987 | 183 | 1987 |
| Efficacy and safety of peginterferon alfa‐2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis S Bruno, ML Shiffman, SK Roberts, EJ Gane, D Messinger, ... Hepatology 51 (2), 388-397, 2010 | 182 | 2010 |
| Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial S Bruno, P Maisonneuve, P Castellana, N Rotmensz, S Rossi, ... bmj 330 (7497), 932, 2005 | 146 | 2005 |
| Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study S Bruno, M Zuin, A Crosignani, S Rossi, F Zadra, L Roffi, M Borzio, ... The American journal of gastroenterology 104 (5), 1147, 2009 | 136 | 2009 |
| Human leukocyte antigen class II and III alleles and severity of hepatitis C virus–related chronic liver disease M Asti, M Martinetti, C Zavaglia, MC Cuccia, L Gusberti, C Tinelli, ... Hepatology 29 (4), 1272-1279, 1999 | 118 | 1999 |
